Position in ANNX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,188,403
+$372,786 QoQ
Shares Held
395,019
+9.2% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 86.02143188049183.ToString("F0")%
Shared 0.ToString("F0")%
None 13.978568119508175.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. ANNX ranks #128 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in ANNX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,188,403 | 395,019 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,815,617 | 361,677 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $939,971 | 308,188 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $722,513 | 301,048 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $557,185 | 288,698 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,182,699 | 230,546 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,327,973 | 224,320 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,264,360 | 258,033 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,295,015 | 180,616 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $609,616 | 134,277 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $364,092 | 154,277 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $543,054 | 154,277 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $145,017 | 37,667 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $194,738 | 37,667 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $109,182 | 17,667 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $270,381 | 99,041 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,163,706 | 101,280 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,923,640 | 103,366 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,124,606 | 94,385 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,184,604 | 78,470 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $1,123,044 | 37,150 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||